- Filed
- Nov 13, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 8, 2024 | 16.1M sh |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $26.1M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $87.1M |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $1.78M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $15.4M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $15.25M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $45.87M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $58.25M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $92.14M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $58.25M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $92.17M |
| Cost Of Revenue | Q3 2024 · Sep 30, 2024 | $0 |
| Cost Of Revenue | Q3 2024 · Sep 30, 2023 | $91.55M |
| Revenue | Q3 2024 · Sep 30, 2024 | $0 |
| Revenue | Q3 2024 · Sep 30, 2023 | $2.34M |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 15.95M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 15.94M sh |
| Capex | Q3 2024 · Sep 30, 2023 | $10.15M |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$120.01M |
| Stockholders Equity | Q3 2024 · Sep 30, 2023 | $13.69M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | $28.97M |
| Stockholders Equity restated | Q3 2024 · Dec 31, 2022 | $351.77M |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$1.03 |
| Eps Diluted restated | Q3 2024 · Sep 30, 2023 | −$21.38 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$1.03 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$21.38 |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $5.72M |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $32.45M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$16.51M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$342.72M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$17.5M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$345.29M |